This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| IG-EPN | |
|---|---|
| Name | IG-EPN |
| Specialty | Neurology; Neurosurgery; Pathology |
IG-EPN IG-EPN is a focal neoplastic entity characterized by epithelial and neuronal phenotypes arising within the posterior fossa and supratentorial compartments. It occupies a niche in contemporary neuropathology and neuro-oncology classification schemes alongside entities described in studies associated with World Health Organization, International Agency for Research on Cancer, and major academic centers such as Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital and Massachusetts General Hospital. IG-EPN has been discussed in comparative series with lesions reported from institutions including Great Ormond Street Hospital, St. Jude Children's Research Hospital, Hospital for Sick Children (Toronto), and consortia such as Children's Oncology Group and European Organisation for Research and Treatment of Cancer.
IG-EPN represents a morphogenetic group first delineated in integrated molecular-histologic studies conducted at academic hubs including Harvard Medical School, University of Cambridge, University of Oxford, Stanford University, and University of California, San Francisco. Case series described in journals associated with The Lancet, New England Journal of Medicine, Nature Medicine, Brain, and Acta Neuropathologica highlight IG-EPN's unique combination of epithelial differentiation, neuronal markers, and regional predilection. Comparative references include tumor classes such as ependymoma, medulloblastoma, pineoblastoma, anaplastic astrocytoma, and rarer lesions cataloged by European Society for Paediatric Oncology investigators.
Reports implicate aberrant developmental pathways involving signaling cascades studied at centers like Broad Institute, Cold Spring Harbor Laboratory, Salk Institute, and Max Planck Institute for Molecular Genetics. Molecular profiling links IG-EPN to alterations in loci also described in studies of TP53, TERT, EGFR, PDGFRA, NF1, and chromatin regulators profiled at Wellcome Trust Sanger Institute and The Cancer Genome Atlas. Epigenetic signatures overlap with methylation clusters characterized by researchers at German Cancer Research Center (DKFZ) and DKFZ-Heidelberg, while transcriptomic analyses reference pathways elucidated by groups at European Bioinformatics Institute and Broad Institute. Developmental neurobiology work from Columbia University and Yale School of Medicine informs hypotheses of progenitor cell origin in regions comparable to those implicated in rhombic lip and ventricular zone studies from University of California, San Diego.
Clinically, IG-EPN presents with focal signs and raised intracranial pressure described in case reports from Seattle Children's Hospital, Children’s National Hospital (Washington, D.C.), and tertiary centers such as Cleveland Clinic and Karolinska University Hospital. Presentations mirror symptoms cataloged in literature on posterior fossa lesions at Mayo Clinic and pediatric series from Nationwide Children's Hospital. Diagnostic workflows incorporate protocols from American Academy of Neurology, American Association of Neurological Surgeons, European Society for Medical Oncology, and National Comprehensive Cancer Network guidelines, integrating neurologic examination, standardized neuroimaging, and molecular panels developed by institutions like Foundation Medicine and Guardant Health.
Neuroimaging patterns are reported in radiology series from Johns Hopkins Hospital Radiology, Massachusetts General Hospital Radiology, and UCLA Medical Center, with features overlapping those of ependymoma and choroid plexus tumor in MRI sequences described by authors in Radiology and AJNR American Journal of Neuroradiology. Histopathologic diagnosis relies on immunohistochemistry and molecular assays performed at reference labs including Mayo Clinic Laboratories, UK NEQAS, and university pathology departments at University of Toronto and UCSF Medical Center. Morphology shows epithelial nests, neuronal marker expression similar to profiles reported for synaptophysin-positive tumors, and proliferative indices consistent with data from Ki-67 studies published by groups at Memorial Sloan Kettering Cancer Center.
Management strategies reflect multimodal approaches practiced at Johns Hopkins Hospital, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Royal Marsden Hospital, and pediatric centers such as St. Jude Children's Research Hospital. Surgical resection techniques draw on neurosurgical atlases authored by surgeons from Barrow Neurological Institute and The Walton Centre. Adjuvant therapies include focal radiotherapy regimens used at University College London Hospitals and systemic options informed by trials from European Organisation for Research and Treatment of Cancer and Children's Oncology Group. Molecularly targeted agents are considered based on genomic reports from The Cancer Genome Atlas and precision oncology experiences reported by Dana-Farber Cancer Institute and Sanger Institute collaborators.
Outcome data derive from retrospective cohorts assembled at Mayo Clinic, Memorial Sloan Kettering Cancer Center, Karolinska University Hospital, and multinational registries coordinated by International Society of Paediatric Oncology. Reported prognostic factors echo those identified in studies of ependymoma and medulloblastoma—extent of resection, molecular subgroup, and response to adjuvant therapy—documented in outcome analyses published in The Lancet Oncology and Journal of Clinical Oncology.
Epidemiologic descriptions are based on case series from referral centers including Great Ormond Street Hospital, Seattle Children's Hospital, Hospital for Sick Children (Toronto), and national registries such as those maintained by Surveillance, Epidemiology, and End Results Program and Eurocare. Risk factor investigations reference familial cancer syndromes cataloged at International Agency for Research on Cancer and variant analyses reported by ClinVar-linked studies in collaboration with National Institutes of Health groups.
Category:Central nervous system neoplasms